A new personalised immunotherapy for the deadly paediatric cancer neuroblastoma.
Chief Investigator: Dr Veronika Bandara
Funding Amount : $100,000
Recipient: The University of Adelaide
Overview: Neuroblastoma is a deadly paediatric cancer. We will test a new personalised immunotherapy, made by modifying the patient’s own immune cells, as a treatment for neuroblastoma. Preliminary studies showed high cytotoxicity against neuroblastoma cell lines, and now further studies are needed to prove the safety and efficacy of this immunotherapy.